CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | indolyl alcohol |
|
Accession: | CHEBI:38467
|
browse the term
|
Synonyms: | related_synonym: | indolyl alcohols |
|
|
|
G |
4930474N05Rikl1 |
RIKEN cDNA 4930474N05 gene like 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of 4930474N05RIKL1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:40,617,254...40,619,561
|
|
G |
A1bg |
alpha-1-B glycoprotein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of A1BG mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of A1BG mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 7:92,493,934...92,498,460
Ensembl chr 7:92,494,372...92,498,097
|
|
G |
A2m |
alpha-2-macroglobulin |
affects expression |
EXP |
indole-3-carbinol affects the expression of A2M mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aamdc |
adipogenesis associated, Mth938 domain containing |
affects expression |
EXP |
indole-3-carbinol affects the expression of AAMDC mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression multiple interactions |
ISO EXP |
indole-3-carbinol results in decreased expression of ABCB1 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCB1A mRNA |
CTD |
PMID:16082211 PMID:22129741 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ABCB1B mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCB1B mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression affects expression |
EXP |
indole-3-carbinol results in increased expression of ABCC1 mRNA indole-3-carbinol affects the expression of ABCC1 mRNA |
CTD |
PMID:11752103 PMID:21396975 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
indole-3-carbinol results in increased expression of ABCC2 mRNA |
CTD |
PMID:11752103 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ABCC3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCC3 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ABCC4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCC4 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ABCD2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCD2 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ABCD3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases expression |
ISO |
indole-3-carbinol results in increased expression of ABCG2 mRNA |
CTD |
PMID:17077187 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg3l1 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ABCG3L1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:5,124,541...5,177,265
Ensembl chr14:5,124,353...5,177,184
|
|
G |
Abcg3l3 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ABCG3L3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:4,844,161...4,892,194
Ensembl chr14:4,844,218...4,892,194
|
|
G |
Abcg3l4 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ABCG3L4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:4,545,206...4,590,223
Ensembl chr14:4,545,223...4,585,347
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ABCG5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG5 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ABCG8 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG8 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
affects expression |
EXP |
indole-3-carbinol affects the expression of ABHD2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
|
|
G |
Abhd8 |
abhydrolase domain containing 8 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABHD8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667
|
|
G |
Abi2 |
abl-interactor 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABI2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:61,827,186...61,905,703
Ensembl chr 9:61,827,139...61,905,699
|
|
G |
Acad8 |
acyl-CoA dehydrogenase family, member 8 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACAD8 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:25,382,271...25,406,404
Ensembl chr 8:25,382,273...25,406,414
|
|
G |
Acer2 |
alkaline ceramidase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACER2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Acer3 |
alkaline ceramidase 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACER3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACOT1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot3 |
acyl-CoA thioesterase 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACOT4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acot8 |
acyl-CoA thioesterase 8 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACOT8 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:153,531,192...153,542,851
Ensembl chr 3:153,531,193...153,542,851
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACOT9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
|
|
G |
Acp3 |
acid phosphatase 3 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ACP3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACP3 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACSL3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acsm2 |
acyl-CoA synthetase medium-chain family member 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACSM3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSM5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ACSM5 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACTA2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Acyp1 |
acylphosphatase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ACYP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
|
|
G |
Adamts2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADAMTS2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:34,920,992...35,126,465
Ensembl chr10:34,921,049...35,123,821
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ADAMTSL4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
|
|
G |
Adat2 |
adenosine deaminase, tRNA-specific 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ADAT2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:7,954,520...7,975,254
Ensembl chr 1:7,954,631...7,975,251
|
|
G |
Adcy10 |
adenylate cyclase 10 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ADCY10 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ADGRB1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902
|
|
G |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:142,299,190...142,362,540
Ensembl chr 5:142,331,329...142,362,540
|
|
G |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ADGRB3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:27,421,168...28,148,979
Ensembl chr 9:27,421,168...28,148,855
|
|
G |
Adgrg2 |
adhesion G protein-coupled receptor G2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
|
|
G |
Adgrg6 |
adhesion G protein-coupled receptor G6 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ADGRG6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ADGRV1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
|
|
G |
Adissp |
adipose secreted signaling protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of ADISSP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:118,364,730...118,378,881
Ensembl chr 3:118,362,363...118,378,838
|
|
G |
Adora1 |
adenosine A1 receptor |
affects expression |
EXP |
indole-3-carbinol affects the expression of ADORA1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Aebp1 |
AE binding protein 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AEBP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
|
|
G |
Afg2a |
AFG2 AAA ATPase homolog A |
affects expression |
EXP |
indole-3-carbinol affects the expression of AFG2A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:120,306,417...120,497,707
Ensembl chr 2:120,306,412...120,497,705
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
affects expression |
EXP |
indole-3-carbinol affects the expression of AGTR1A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahi1 |
Abelson helper integration site 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AHI1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:15,762,485...15,891,213
Ensembl chr 1:15,762,462...15,891,041
|
|
G |
Ahnak |
AHNAK nucleoprotein |
affects expression |
EXP |
indole-3-carbinol affects the expression of AHNAK mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions increases expression affects expression decreases expression |
ISO EXP |
[indole-3-carbinol co-treated with DDT] results in increased expression of AHR mRNA; ARNT protein affects the reaction [indole-3-carbinol results in decreased expression of AHR protein]; indole-3-carbinol binds to and results in increased activity of AHR protein; indole-3-carbinol promotes the reaction [AHR protein binds to BRCA1 protein] [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AHR mRNA; AHR protein promotes the reaction [indole-3-carbinol results in increased expression of CYP1A1 mRNA]; indole-3-carbinol binds to and results in increased activity of AHR protein; indole-3-carbinol inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] indole-3-carbinol results in increased expression of AHR mRNA AHR protein affects the reaction [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of IL22 mRNA]; AHR protein affects the susceptibility to [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased secretion of IL10 protein]; AHR protein affects the susceptibility to [indole-3-carbinol results in decreased expression of ITGAX protein]; AHR protein affects the susceptibility to [indole-3-carbinol results in increased expression of CD86 protein] indole-3-carbinol affects the expression of AHR mRNA |
CTD |
PMID:8384853 PMID:9407059 PMID:11752103 PMID:17311112 PMID:18259752 PMID:21396975 PMID:21948866 PMID:22129741 PMID:35295139 PMID:37217010 More...
|
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akap5 |
A-kinase anchoring protein 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AKAP5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
|
|
G |
Akip1 |
A-kinase interacting protein 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AKIP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:163,734,730...163,743,648
Ensembl chr 1:163,734,798...163,743,648
|
|
G |
Akirin1 |
akirin 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AKIRIN1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:135,989,378...136,004,782
Ensembl chr 5:135,989,465...136,004,762
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
increases expression |
EXP |
indole-3-carbinol results in increased expression of AKR7A5 |
CTD |
PMID:9806166 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
affects expression multiple interactions increases activity |
EXP |
indole-3-carbinol affects the expression of AKR7A3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA indole-3-carbinol results in increased activity of AKR7A3 protein |
CTD |
PMID:9328168 PMID:21396975 PMID:22129741 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
indole-3-carbinol results in decreased expression of and results in decreased phosphorylation of AKT1 protein indole-3-carbinol results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:29992829 PMID:33118390 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alas2 |
5'-aminolevulinate synthase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ALAS2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression affects expression multiple interactions |
ISO EXP |
indole-3-carbinol results in increased expression of ALDH1A1 mRNA indole-3-carbinol affects the expression of ALDH1A1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:21396975 PMID:21948866 PMID:22129741 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a2 |
aldehyde dehydrogenase 1 family, member A2 |
decreases expression multiple interactions |
ISO |
indole-3-carbinol results in decreased expression of ALDH1A2 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in decreased expression of ALDH1A2 mRNA] |
CTD |
PMID:21948866 |
|
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ALDH3A1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ALDH3A1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
affects expression |
EXP |
indole-3-carbinol affects the expression of ALOX15 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Alpk1 |
alpha-kinase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ALPK1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
EXP |
indole-3-carbinol affects the reaction [Thioacetamide results in increased expression of ALPL protein] |
CTD |
PMID:37150287 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Amdhd1 |
amidohydrolase domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AMDHD1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:28,043,923...28,059,156
Ensembl chr 7:28,043,716...28,059,156
|
|
G |
Amdhd2 |
amidohydrolase domain containing 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AMDHD2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:13,187,579...13,196,148
Ensembl chr10:13,187,578...13,196,095
|
|
G |
Amfr |
autocrine motility factor receptor |
affects expression |
EXP |
indole-3-carbinol affects the expression of AMFR mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:10,996,705...11,032,260
Ensembl chr19:10,996,099...11,032,247
|
|
G |
Anapc10 |
anaphase promoting complex subunit 10 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANAPC10 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:28,152,299...28,205,552
Ensembl chr19:28,152,299...28,205,467
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd22 |
ankyrin repeat domain 22 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANKRD22 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:231,639,035...231,670,537
Ensembl chr 1:231,639,314...231,670,381
|
|
G |
Ankrd29 |
ankyrin repeat domain 29 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ANKRD29 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ANKRD29 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr18:3,436,301...3,494,292
Ensembl chr18:3,436,303...3,494,296
|
|
G |
Ankrd37 |
ankyrin repeat domain 37 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANKRD37 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
|
|
G |
Ankrd42 |
ankyrin repeat domain 42 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANKRD42 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:146,648,080...146,691,086
Ensembl chr 1:146,648,080...146,691,108
|
|
G |
Ankrd65 |
ankyrin repeat domain 65 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANKRD65 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:166,398,359...166,400,616
Ensembl chr 5:166,397,748...166,400,953
|
|
G |
Anp32e |
acidic nuclear phosphoprotein 32 family member E |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANP32E mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
|
|
G |
Anxa5 |
annexin A5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANXA5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Anxa7 |
annexin A7 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ANXA7 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
indole-3-carbinol results in increased expression of APAF1 protein |
CTD |
PMID:29775573 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apbb1 |
amyloid beta precursor protein binding family B member 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of APBB1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:159,896,889...159,920,505
Ensembl chr 1:159,896,880...159,920,627
|
|
G |
Apeg3 |
antisense paternally expressed gene 3 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of APEG3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of APEG3 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:67,121,402...67,122,333
Ensembl chr 1:67,121,900...67,122,181 Ensembl chr 1:67,121,900...67,122,181
|
|
G |
Aph1b |
aph-1 homolog B, gamma secretase subunit |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of APH1B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:67,429,198...67,454,735
Ensembl chr 8:67,429,198...67,450,243
|
|
G |
Apip |
APAF1 interacting protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of APIP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:89,431,964...89,458,000
Ensembl chr 3:89,432,037...89,458,340
|
|
G |
App |
amyloid beta precursor protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of APP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp1 |
aquaporin 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of AQP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Ar |
androgen receptor |
decreases activity multiple interactions |
ISO EXP |
indole-3-carbinol results in decreased activity of AR protein indole-3-carbinol inhibits the reaction [bisphenol A results in increased expression of AR protein] |
CTD |
PMID:16082211 PMID:24257414 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap18 |
Rho GTPase activating protein 18 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ARHGAP18 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
|
|
G |
Arhgef9 |
Cdc42 guanine nucleotide exchange factor 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ARHGEF9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:59,919,560...60,077,538
Ensembl chr X:59,920,870...60,077,513
|
|
G |
Arl13a |
ARF like GTPase 13A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARL13A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr X:97,380,370...97,406,704
Ensembl chr X:97,380,390...97,406,702
|
|
G |
Arl4a |
ARF like GTPase 4A |
affects expression |
EXP |
indole-3-carbinol affects the expression of ARL4A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
|
|
G |
Arl6 |
ARF like GTPase 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ARL6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:40,711,878...40,738,254
Ensembl chr11:40,712,022...40,737,937
|
|
G |
Armcx1 |
armadillo repeat containing, X-linked 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ARMCX1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ARMCX1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
|
|
G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ARMCX3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
ARNT protein affects the reaction [indole-3-carbinol results in decreased expression of AHR protein] |
CTD |
PMID:37217010 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arpp21 |
cAMP regulated phosphoprotein 21 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ARPP21 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Arv1 |
ARV1 homolog, fatty acid homeostasis modulator |
affects expression |
EXP |
indole-3-carbinol affects the expression of ARV1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:52,692,337...52,704,156
Ensembl chr19:52,692,337...52,704,156
|
|
G |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ASAP2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975
|
|
G |
Asb10 |
ankyrin repeat and SOCS box-containing 10 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ASB10 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:10,630,318...10,644,270
Ensembl chr 4:10,630,448...10,639,060
|
|
G |
Asb5 |
ankyrin repeat and SOCS box-containing 5 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ASB5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ASB5 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr16:37,237,869...37,305,207
Ensembl chr16:37,235,405...37,278,109
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ASNS mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASNS mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Aspg |
asparaginase |
affects expression |
EXP |
indole-3-carbinol affects the expression of ASPG mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
|
|
G |
Astl |
astacin like metalloendopeptidase |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ASTL mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ASTL mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 3:114,563,135...114,580,295
Ensembl chr 3:114,563,135...114,578,868
|
|
G |
Atad2 |
ATPase family, AAA domain containing 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATAD2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
|
|
G |
Atf3 |
activating transcription factor 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATF3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp2b2 |
ATPase plasma membrane Ca2+ transporting 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATP2B2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
|
|
G |
Atp5if1 |
ATP synthase inhibitory factor subunit 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATP5IF1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
|
|
G |
Atp5mc3 |
ATP synthase membrane subunit c locus 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATP5MC3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279
|
|
G |
Atp6ap1l |
ATPase H+ transporting accessory protein 1 like |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATP6AP1L mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:22,037,542...22,079,376
Ensembl chr 2:22,037,563...22,065,038
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ATP6V0D2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATP6V1C2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Atp8b2 |
ATPase phospholipid transporting 8B2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ATP8B2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:175,378,514...175,402,265
Ensembl chr 2:175,378,517...175,401,883
|
|
G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ATPAF1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:129,265,789...129,292,463
Ensembl chr 5:129,266,404...129,293,556
|
|
G |
Atrnl1 |
attractin like 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ATRNL1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ATRNL1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:256,670,976...257,219,291
Ensembl chr 1:256,670,627...257,213,197
|
|
G |
Aurkb |
aurora kinase B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AURKB mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
affects expression |
EXP |
indole-3-carbinol affects the expression of AVPR1A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
B3galt5 |
Beta-1,3-galactosyltransferase 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GALT5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of B3GNT2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
B3gnt9 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of B3GNT9 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of B3GNT9 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr19:33,129,740...33,134,048
Ensembl chr19:33,128,142...33,132,344
|
|
G |
B9d1 |
B9 domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of B9D1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:46,186,222...46,196,309
Ensembl chr10:46,186,691...46,196,008
|
|
G |
Bahd1 |
bromo adjacent homology domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BAHD1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:105,891,207...105,914,414
Ensembl chr 3:105,892,478...105,914,410
|
|
G |
Barx2 |
BARX homeobox 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BARX2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
indole-3-carbinol results in increased expression of BAX; indole-3-carbinol results in increased expression of BAX protein |
CTD |
PMID:16082211 PMID:29775573 PMID:33118390 PMID:34085558 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbof1 |
basal body orientation factor 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BBOF1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:104,055,246...104,081,036
Ensembl chr 6:104,055,241...104,082,071
|
|
G |
Bbs5 |
Bardet-Biedl syndrome 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BBS5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:54,410,429...54,431,831
Ensembl chr 3:54,410,775...54,431,829
|
|
G |
Bbs7 |
Bardet-Biedl syndrome 7 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of BBS7 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BBS7 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 2:119,434,760...119,474,665
Ensembl chr 2:119,434,760...119,474,396
|
|
G |
Bcas1 |
brain enriched myelin associated protein 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCAS1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:159,136,077...159,219,072
Ensembl chr 3:159,136,083...159,219,106
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
indole-3-carbinol results in decreased expression of BCL2; indole-3-carbinol results in decreased expression of BCL2 protein Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of BCL2 protein]; indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2 protein] |
CTD |
PMID:15811958 PMID:16082211 PMID:29775573 PMID:33118390 PMID:34085558 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] |
CTD |
PMID:15811958 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression multiple interactions |
ISO |
indole-3-carbinol results in decreased expression of BCL2L1; indole-3-carbinol results in decreased expression of BCL2L1 protein Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of BCL2L1 protein] |
CTD |
PMID:16082211 PMID:29992829 PMID:33118390 PMID:34085558 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
indole-3-carbinol results in increased expression of BCL2L11 protein |
CTD |
PMID:33118390 PMID:34085558 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl6 |
BCL6, transcription repressor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BCL6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BDH2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bex3 |
brain expressed X-linked 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BEX3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:99,273,270...99,274,799
Ensembl chr X:99,273,161...99,274,800
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BHLHE40 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] |
CTD |
PMID:15811958 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC3 protein] |
CTD |
PMID:15811958 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] indole-3-carbinol results in decreased expression of BIRC5 |
CTD |
PMID:15811958 PMID:16082211 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blnk |
B-cell linker |
affects expression |
EXP |
indole-3-carbinol affects the expression of BLNK mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bloc1s6 |
biogenesis of lysosomal organelles complex 1 subunit 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BLOC1S6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:109,816,397...109,826,528
Ensembl chr 3:109,816,366...109,828,308
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmp2k |
BMP-2 inducible kinase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BMP2K mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:12,481,194...12,579,411
Ensembl chr14:12,484,729...12,579,134
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BMP4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bmp5 |
bone morphogenetic protein 5 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of BMP5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925
|
|
G |
Bms1 |
BMS1 ribosome biogenesis factor |
affects expression |
EXP |
indole-3-carbinol affects the expression of BMS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:151,558,163...151,595,187
Ensembl chr 4:151,558,163...151,595,127
|
|
G |
Borcs8 |
BLOC-1 related complex subunit 8 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BORCS8 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:19,274,305...19,280,969
Ensembl chr16:19,274,023...19,280,339
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions increases expression |
ISO |
[indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein; BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]]; indole-3-carbinol promotes the reaction [AHR protein binds to BRCA1 protein] indole-3-carbinol results in increased expression of BRCA1 mRNA; indole-3-carbinol results in increased expression of BRCA1 protein |
CTD |
PMID:11110848 PMID:16434996 PMID:18259752 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
increases expression multiple interactions affects expression |
ISO EXP |
indole-3-carbinol results in increased expression of BRCA2 mRNA; indole-3-carbinol results in increased expression of BRCA2 protein [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA2 protein indole-3-carbinol affects the expression of BRCA2 mRNA |
CTD |
PMID:16434996 PMID:21396975 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Btf3l4 |
basic transcription factor 3-like 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BTF3L4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:123,567,902...123,587,527
Ensembl chr 5:123,567,907...123,586,866
|
|
G |
Btn1a1 |
butyrophilin, subfamily 1, member A1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of BTN1A1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr17:41,653,499...41,664,246
Ensembl chr17:41,654,249...41,664,272
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of BZW2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
C16h10orf71 |
similar to human chromosome 10 open reading frame 71 |
affects expression |
EXP |
indole-3-carbinol affects the expression of C16H10ORF71 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:7,910,597...7,961,900
Ensembl chr16:7,910,433...7,961,958
|
|
G |
C19h16orf74 |
similar to human chromosome 16 open reading frame 74 |
affects expression |
EXP |
indole-3-carbinol affects the expression of C19H16ORF74 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:48,660,288...48,686,287
Ensembl chr19:48,660,288...48,686,349
|
|
G |
C1h11orf24 |
similar to human chromosome 11 open reading frame 24 |
affects expression |
EXP |
indole-3-carbinol affects the expression of C1H11ORF24 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:200,945,188...200,953,953
Ensembl chr 1:200,945,180...200,962,585
|
|
G |
C5ar1 |
complement C5a receptor 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of C5AR1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:76,948,622...76,959,826
|
|
G |
C7 |
complement C7 |
affects expression |
EXP |
indole-3-carbinol affects the expression of C7 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
|
|
G |
C8h15orf61 |
similar to human chromosome 15 open reading frame 61 |
affects expression |
EXP |
indole-3-carbinol affects the expression of C8H15ORF61 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:63,868,125...63,872,863
Ensembl chr 8:63,868,125...63,872,751
|
|
G |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CABCOCO1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr20:20,058,492...20,167,973
Ensembl chr20:20,058,454...20,167,725
|
|
G |
Cables1 |
Cdk5 and Abl enzyme substrate 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CABLES1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CACNA1G mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Calr3 |
calreticulin 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CALR3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CAMK2N1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Car3 |
carbonic anhydrase 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CAR3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car6 |
carbonic anhydrase 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CAR6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases cleavage decreases expression |
ISO EXP |
indole-3-carbinol results in increased activity of CASP3 protein indole-3-carbinol results in decreased expression of and results in increased cleavage of CASP3 protein; indole-3-carbinol results in increased cleavage of and results in increased activity of CASP3 protein indole-3-carbinol results in increased cleavage of CASP3 protein indole-3-carbinol results in decreased expression of CASP3 protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of CASP3 protein] |
CTD |
PMID:16082211 PMID:20335513 PMID:29775573 PMID:29992829 PMID:33118390 PMID:34085558 PMID:37150287 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CASP4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
decreases expression multiple interactions increases cleavage |
ISO |
indole-3-carbinol results in decreased expression of CASP7 protein indole-3-carbinol results in decreased expression of and results in increased cleavage of CASP7 protein indole-3-carbinol results in increased cleavage of CASP7 protein |
CTD |
PMID:29992829 PMID:33118390 PMID:34085558 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
increases activity multiple interactions increases cleavage |
ISO EXP |
indole-3-carbinol results in increased activity of CASP9 protein indole-3-carbinol results in decreased expression of and results in increased cleavage of CASP9 protein; indole-3-carbinol results in increased cleavage of and results in increased activity of CASP9 protein indole-3-carbinol results in increased cleavage of CASP9 protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of CASP9 protein] |
CTD |
PMID:16082211 PMID:20335513 PMID:29775573 PMID:33118390 PMID:34085558 PMID:37150287 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases activity |
ISO EXP |
indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased activity of CAT protein] indole-3-carbinol results in increased activity of CAT protein indole-3-carbinol inhibits the reaction [Thioacetamide results in decreased expression of CAT protein] |
CTD |
PMID:29775573 PMID:37150287 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Catsper2 |
cation channel, sperm associated 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CATSPER2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:108,368,654...108,389,380
Ensembl chr 3:108,368,668...108,388,050
|
|
G |
Cavin3 |
caveolae associated protein 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CAVIN3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
|
|
G |
Cby1 |
chibby 1, beta catenin antagonist |
affects expression |
EXP |
indole-3-carbinol affects the expression of CBY1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:111,216,835...111,223,305
|
|
G |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
affects expression |
EXP |
indole-3-carbinol affects the expression of CC2D2A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949
|
|
G |
Ccdc121 |
coiled-coil domain containing 121 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCDC121 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:24,970,845...24,973,451
Ensembl chr 6:24,970,833...24,973,478
|
|
G |
Ccdc152 |
coiled-coil domain containing 152 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCDC152 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:52,507,987...52,532,880
Ensembl chr 2:52,507,981...52,532,826
|
|
G |
Ccdc158 |
coiled-coil domain containing 158 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCDC158 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:15,411,178...15,468,579
Ensembl chr14:15,411,163...15,468,581
|
|
G |
Ccdc178 |
coiled-coil domain containing 178 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCDC178 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:13,074,834...13,472,732
Ensembl chr18:13,075,468...13,472,160
|
|
G |
Ccdc28a |
coiled-coil domain containing 28A |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCDC28A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
|
|
G |
Ccdc43 |
coiled-coil domain containing 43 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCDC43 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:87,650,554...87,662,788
Ensembl chr10:87,650,556...87,662,818
|
|
G |
Ccdc59 |
coiled-coil domain containing 59 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCDC59 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:41,142,760...41,149,143
Ensembl chr 7:41,142,760...41,149,143
|
|
G |
Ccdc71l |
coiled-coil domain containing 71-like |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCDC71L mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:48,960,020...48,964,112
Ensembl chr 6:48,960,191...48,960,841 Ensembl chr 6:48,960,191...48,960,841
|
|
G |
Ccdc88b |
coiled-coil domain containing 88B |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCDC88B mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
ISO |
indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of CCL1 mRNA] |
CTD |
PMID:27783115 |
|
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCL11 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCL21 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCL4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccn1 |
cellular communication network factor 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCN1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccn2 |
cellular communication network factor 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCN2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCNA2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CCNB1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CCNB1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression affects expression |
ISO EXP |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CCND1 protein] indole-3-carbinol results in decreased expression of CCND1 indole-3-carbinol affects the expression of CCND1 mRNA |
CTD |
PMID:15811958 PMID:16082211 PMID:21396975 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCND2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
affects localization multiple interactions decreases expression |
ISO |
indole-3-carbinol affects the localization of CCNE1 protein indole-3-carbinol affects the localization of [CDK2 protein binds to CCNE1 protein alternative form]; indole-3-carbinol promotes the reaction [CDK2 protein binds to CCNE1 protein alternative form] indole-3-carbinol results in decreased expression of CCNE1 |
CTD |
PMID:15611077 PMID:16082211 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CCNE2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccnf |
cyclin F |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCNF mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Ccnq |
cyclin Q |
affects expression |
EXP |
indole-3-carbinol affects the expression of CCNQ mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:63,646,532...63,647,695
Ensembl chr10:63,646,527...63,647,961
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
increases expression |
ISO |
indole-3-carbinol results in increased expression of CCR5 protein |
CTD |
PMID:27783115 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
multiple interactions |
ISO |
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of CCR7 protein |
CTD |
PMID:27783115 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd14 |
CD14 molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD14 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd207 |
CD207 molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD207 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:116,155,229...116,161,587
Ensembl chr 4:116,155,212...116,161,518
|
|
G |
Cd24 |
CD24 molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD24 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd300c2l1 |
CD300C molecule 2 like 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD300C2L1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:100,136,144...100,140,607
Ensembl chr10:100,136,867...100,140,427
|
|
G |
Cd38 |
CD38 molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD38 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions decreases expression |
ISO |
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of CD40 protein; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 protein] indole-3-carbinol results in decreased expression of CD40 protein |
CTD |
PMID:21948866 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd46 |
CD46 molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD46 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Cd69 |
Cd69 molecule |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of CD69 protein] |
CTD |
PMID:24200994 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Cd80 |
Cd80 molecule |
increases expression multiple interactions |
ISO |
indole-3-carbinol results in increased expression of CD80 protein [Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of CD80 protein; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of CD80 protein] |
CTD |
PMID:21948866 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd83 |
CD83 molecule |
decreases expression |
ISO |
indole-3-carbinol results in decreased expression of CD83 protein |
CTD |
PMID:27783115 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cd84 |
CD84 molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD84 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:84,327,580...84,367,153
Ensembl chr13:84,327,553...84,362,076
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions decreases expression increases expression |
ISO |
[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of CD86 protein; AHR protein affects the susceptibility to [indole-3-carbinol results in increased expression of CD86 protein]; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of CD86 protein] indole-3-carbinol results in decreased expression of CD86 protein [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of CD86 protein |
CTD |
PMID:21948866 PMID:27783115 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cd9 |
CD9 molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of CD9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Cdc25b |
cell division cycle 25B |
affects expression |
EXP |
indole-3-carbinol affects the expression of CDC25B mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdca8 |
cell division cycle associated 8 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDCA8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
EXP |
[Hemin co-treated with indole-3-carbinol co-treated with 1,2-Dimethylhydrazine] affects the expression of CDH1 mRNA |
CTD |
PMID:29269057 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh11 |
cadherin 11 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDH11 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdh13 |
cadherin 13 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CDH13 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdh17 |
cadherin 17 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CDH17 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:25,262,820...25,314,884
Ensembl chr 5:25,262,758...25,314,884
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
affects localization multiple interactions decreases activity decreases expression |
ISO |
indole-3-carbinol affects the localization of CDK2 protein indole-3-carbinol affects the localization of [CDK2 protein binds to CCNE1 protein alternative form]; indole-3-carbinol promotes the reaction [CDK2 protein binds to CCNE1 protein alternative form] indole-3-carbinol analog results in decreased activity of CDK2 protein; indole-3-carbinol results in decreased activity of CDK2 protein indole-3-carbinol results in decreased expression of CDK2 |
CTD |
PMID:15611077 PMID:16082211 PMID:18023427 PMID:20570586 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression decreases activity decreases expression |
ISO |
indole-3-carbinol analog results in increased expression of CDK4 protein indole-3-carbinol analog results in decreased activity of CDK4 protein indole-3-carbinol results in decreased expression of CDK4 |
CTD |
PMID:16082211 PMID:20570586 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
multiple interactions decreases activity decreases expression increases expression |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDK6 mRNA indole-3-carbinol analog inhibits the reaction [SP1 protein binds to CDK6 promoter] indole-3-carbinol analog results in decreased activity of CDK6 promoter; indole-3-carbinol analog results in decreased activity of CDK6 protein indole-3-carbinol analog results in decreased expression of CDK6 mRNA; indole-3-carbinol analog results in decreased expression of CDK6 protein; indole-3-carbinol results in decreased expression of CDK6 indole-3-carbinol analog results in increased expression of CDK6 mRNA |
CTD |
PMID:16082211 PMID:18023427 PMID:20570586 PMID:22129741 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkl3 |
cyclin-dependent kinase-like 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDKL3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:36,263,212...36,349,268
Ensembl chr10:36,266,977...36,349,268
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression affects expression multiple interactions |
ISO EXP |
indole-3-carbinol analog results in increased expression of CDKN1A protein; indole-3-carbinol results in increased expression of CDKN1A; indole-3-carbinol results in increased expression of CDKN1A mRNA indole-3-carbinol affects the expression of CDKN1A mRNA; indole-3-carbinol affects the expression of CDKN1A protein [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CDKN1A mRNA |
CTD |
PMID:16082211 PMID:17311112 PMID:18025290 PMID:20570586 PMID:21396975 PMID:22129741 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
indole-3-carbinol analog results in increased expression of CDKN1B protein; indole-3-carbinol results in increased expression of CDKN1B; indole-3-carbinol results in increased expression of CDKN1B protein |
CTD |
PMID:16082211 PMID:20570586 PMID:34085558 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
increases expression |
ISO |
indole-3-carbinol results in increased expression of CDKN2B |
CTD |
PMID:16082211 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CDS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cdx1 |
caudal type homeo box 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CDX1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
|
|
G |
Cdx2 |
caudal type homeo box 2 |
multiple interactions |
ISO |
indole-3-carbinol promotes the reaction [CL 075 results in increased expression of CDX2 mRNA] |
CTD |
PMID:27783115 |
|
NCBI chr12:7,726,798...7,733,142
Ensembl chr12:7,726,798...7,733,142
|
|
G |
Ceacam20 |
CEA cell adhesion molecule 20 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CEACAM20 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEACAM20 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:79,622,077...79,643,782
Ensembl chr 1:79,622,077...79,643,782
|
|
G |
Ceacam4 |
CEA cell adhesion molecule 4 |
multiple interactions affects expression |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEACAM10 mRNA indole-3-carbinol affects the expression of CEACAM10 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
|
|
G |
Cenpf |
centromere protein F |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CENPF mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenpk |
centromere protein K |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CENPK mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cenpl |
centromere protein L |
affects expression |
EXP |
indole-3-carbinol affects the expression of CENPL mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
|
|
G |
Cep76 |
centrosomal protein 76 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEP76 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr18:61,174,514...61,208,512
Ensembl chr18:61,178,310...61,208,504
|
|
G |
Cep83 |
centrosomal protein 83 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CEP83 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:29,280,358...29,389,574
Ensembl chr 7:29,280,419...29,389,574
|
|
G |
Cers5 |
ceramide synthase 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CERS5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:130,859,993...130,897,979
Ensembl chr 7:130,859,990...130,897,947
|
|
G |
Cert1 |
ceramide transporter 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CERT1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:27,882,546...27,987,090
Ensembl chr 2:27,882,555...27,987,074
|
|
G |
Ces2c |
carboxylesterase 2C |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CES2C mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CES2C mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:260,391,190...260,398,757
Ensembl chr 1:260,388,902...260,398,790
|
|
G |
Ces2h |
carboxylesterase 2H |
affects expression |
EXP |
indole-3-carbinol affects the expression of CES2H mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions decreases expression |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CFLAR protein] indole-3-carbinol results in decreased expression of CFLAR |
CTD |
PMID:15811958 PMID:16082211 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CHCHD6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHCHD6 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
|
|
G |
Chek1 |
checkpoint kinase 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CHEK1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chid1 |
chitinase domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CHID1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:196,594,357...196,629,700
Ensembl chr 1:196,587,509...196,629,606
|
|
G |
Chka |
choline kinase alpha |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHKA mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp4bl1 |
chromatin modifying protein 4B-like 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CHMP4BL1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:68,049,742...68,050,791
Ensembl chr 4:68,049,705...68,050,676
|
|
G |
Chmp4c |
charged multivesicular body protein 4C |
affects expression |
EXP |
indole-3-carbinol affects the expression of CHMP4C mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
|
|
G |
Chpf |
chondroitin polymerizing factor |
affects expression |
EXP |
indole-3-carbinol affects the expression of CHPF mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
|
|
G |
Chrac1 |
chromatin accessibility complex subunit 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CHRAC1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:105,013,047...105,016,435
Ensembl chr 7:105,013,015...105,017,136
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CHRM2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrnb1 |
cholinergic receptor nicotinic beta 1 subunit |
affects expression |
EXP |
indole-3-carbinol affects the expression of CHRNB1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345
|
|
G |
Chst14 |
carbohydrate sulfotransferase 14 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHST14 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:105,916,481...105,918,538
Ensembl chr 3:105,916,466...105,918,548
|
|
G |
Chtf8 |
chromosome transmission fidelity factor 8 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CHTF8 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:34,782,005...34,792,306
Ensembl chr19:34,781,856...34,792,578
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of CHUK protein] |
CTD |
PMID:15811958 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CIDEA mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIDEA mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cimap1a |
ciliary microtubule associated protein 1A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIMAP1A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:195,926,034...195,929,250
Ensembl chr 1:195,926,041...195,929,248
|
|
G |
Cimap1b |
ciliary microtubule associated protein 1B |
affects expression |
EXP |
indole-3-carbinol affects the expression of CIMAP1B mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:120,444,232...120,447,294
Ensembl chr 7:120,444,232...120,446,749
|
|
G |
Cirbp |
cold inducible RNA binding protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of CIRBP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CISH mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Ckap4 |
cytoskeleton-associated protein 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CKAP4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
|
|
G |
Clcc1 |
chloride channel CLIC-like 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CLCC1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:196,296,350...196,326,914
Ensembl chr 2:196,296,393...196,326,913
|
|
G |
Cldn1 |
claudin 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CLDN1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLDN1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn18 |
claudin 18 |
multiple interactions |
EXP |
indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of CLDN18 mRNA] |
CTD |
PMID:27178563 |
|
NCBI chr 8:100,246,499...100,265,797
Ensembl chr 8:100,247,633...100,273,351
|
|
G |
Clec10a |
C-type lectin domain containing 10A |
affects expression |
EXP |
indole-3-carbinol affects the expression of CLEC10A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
|
|
G |
Clec4g |
C-type lectin domain family 4, member G |
affects expression |
EXP |
indole-3-carbinol affects the expression of CLEC4G mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:1,780,370...1,785,027
Ensembl chr12:1,780,371...1,784,985
|
|
G |
Clec9a |
C-type lectin domain containing 9A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CLEC9A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:162,859,742...162,875,742
Ensembl chr 4:162,860,308...162,875,352
|
|
G |
Clybl |
citramalyl-CoA lyase |
affects expression |
EXP |
indole-3-carbinol affects the expression of CLYBL mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:99,283,644...99,505,697
Ensembl chr15:99,283,650...99,505,695
|
|
G |
Cma1 |
chymase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CMA1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
affects expression |
EXP |
indole-3-carbinol affects the expression of COL14A1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
affects expression |
EXP |
indole-3-carbinol affects the expression of COL1A1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of COLQ mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of COLQ mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of COPG2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
|
|
G |
Coq10b |
coenzyme Q10B |
affects expression |
EXP |
indole-3-carbinol affects the expression of COQ10B mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
|
|
G |
Coro6 |
coronin 6 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CORO6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cox6c-ps1 |
cytochrome c oxidase subunit VIc, pseudogene |
affects expression |
EXP |
indole-3-carbinol affects the expression of COX6C-PS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:52,192,612...52,193,470
Ensembl chr19:52,192,612...52,193,470
|
|
G |
Cox8c |
cytochrome c oxidase subunit 8C |
affects expression |
EXP |
indole-3-carbinol affects the expression of COX8C mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:122,028,566...122,029,889
Ensembl chr 6:122,028,566...122,029,889
|
|
G |
Cpeb2 |
cytoplasmic polyadenylation element binding protein 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CPEB2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:67,787,503...67,839,973
Ensembl chr14:67,787,507...67,840,743
|
|
G |
Cplx1 |
complexin 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPLX1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:1,184,677...1,216,392
|
|
G |
Cplx2 |
complexin 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CPLX2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cpz |
carboxypeptidase Z |
affects expression |
EXP |
indole-3-carbinol affects the expression of CPZ mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
|
|
G |
Crat |
carnitine O-acetyltransferase |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRAT mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRAT mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Crlf2 |
cytokine receptor-like factor 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CRLF2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:103,943...108,643
Ensembl chr14:103,939...108,642
|
|
G |
Cryab |
crystallin, alpha B |
affects expression |
EXP |
indole-3-carbinol affects the expression of CRYAB mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Cryga |
crystallin, gamma A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CRYGA mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYGA mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 9:66,482,176...66,484,638
Ensembl chr 9:66,482,176...66,509,896
|
|
G |
Cryl1 |
crystallin, lambda 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CRYL1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Csmd1 |
CUB and Sushi multiple domains 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CSMD1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CSMD1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CSRP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Cstf3 |
cleavage stimulation factor subunit 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CSTF3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:90,966,415...91,037,669
Ensembl chr 3:90,966,354...91,042,196
|
|
G |
Ctps1 |
CTP synthase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CTPS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctrc |
chymotrypsin C |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CTRC mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:154,147,314...154,156,540
Ensembl chr 5:154,147,316...154,156,528
|
|
G |
Ctsd |
cathepsin D |
decreases expression |
ISO |
indole-3-carbinol results in decreased expression of CTSD protein |
CTD |
PMID:11110848 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctse |
cathepsin E |
affects expression |
EXP |
indole-3-carbinol affects the expression of CTSE mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Cux2 |
cut-like homeobox 2 |
multiple interactions affects expression |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA] indole-3-carbinol affects the expression of CUX2 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxcl17 |
C-X-C motif chemokine ligand 17 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CXCL17 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:80,984,751...80,996,842
Ensembl chr 1:80,984,964...80,996,726
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CXCL9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions |
ISO EXP |
indole-3-carbinol affects the localization of CYCS protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of CYCS protein] |
CTD |
PMID:16082211 PMID:37150287 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression increases activity affects expression |
ISO EXP |
[indole-3-carbinol co-treated with DDT] results in increased expression of CYP1A1 mRNA indole-3-carbinol results in increased expression of CYP1A1 mRNA; indole-3-carbinol results in increased expression of CYP1A1 protein [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A1 mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of CYP1A1 mRNA; AHR protein promotes the reaction [indole-3-carbinol results in increased expression of CYP1A1 mRNA]; indole-3-carbinol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein] indole-3-carbinol results in increased expression of CYP1A1; indole-3-carbinol results in increased expression of CYP1A1 mRNA indole-3-carbinol results in increased activity of CYP1A1 protein indole-3-carbinol affects the expression of CYP1A1 mRNA indole-3-carbinol results in increased expression of CYP1A1; indole-3-carbinol results in increased expression of CYP1A1 mRNA; indole-3-carbinol results in increased expression of CYP1A1 protein |
CTD |
PMID:8384853 PMID:9395520 PMID:9806166 PMID:11339718 PMID:11446830 PMID:11752103 PMID:12147290 PMID:15890477 PMID:17311112 PMID:21203749 PMID:21396975 PMID:21948866 PMID:22129741 PMID:22328411 PMID:24418717 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity affects expression increases expression multiple interactions |
EXP ISO |
indole-3-carbinol results in increased activity of CYP1A2; indole-3-carbinol results in increased activity of CYP1A2 protein indole-3-carbinol affects the expression of CYP1A2 mRNA indole-3-carbinol results in increased expression of CYP1A2 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] indole-3-carbinol results in increased expression of CYP1A2; indole-3-carbinol results in increased expression of CYP1A2 protein indole-3-carbinol results in increased expression of CYP1A2 mRNA |
CTD |
PMID:8384853 PMID:9806166 PMID:12147290 PMID:21396975 PMID:22129741 PMID:22328411 PMID:28357125 More...
|
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions increases expression affects expression |
ISO EXP |
[indole-3-carbinol co-treated with DDT] results in increased expression of CYP1B1 mRNA indole-3-carbinol results in increased expression of CYP1B1 mRNA indole-3-carbinol affects the expression of CYP1B1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1B1 mRNA] |
CTD |
PMID:12147290 PMID:15890477 PMID:17311112 PMID:21396975 PMID:22129741 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp26c1 |
cytochrome P450, family 26, subfamily C, polypeptide 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP26C1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:235,458,961...235,468,433
Ensembl chr 1:235,459,356...235,466,842
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
indole-3-carbinol results in increased expression of CYP2B1; indole-3-carbinol results in increased expression of CYP2B1 protein |
CTD |
PMID:8384853 PMID:9806166 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b12 |
cytochrome P450, family 2, subfamily b, polypeptide 12 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CYP2B12 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2B12 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression affects expression multiple interactions |
EXP |
indole-3-carbinol results in increased expression of CYP2B2; indole-3-carbinol results in increased expression of CYP2B2 protein indole-3-carbinol affects the expression of CYP2B2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2B2 mRNA |
CTD |
PMID:8384853 PMID:9806166 PMID:21396975 PMID:22129741 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CYP2C55 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CYP2C6 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP2C6 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity multiple interactions |
ISO EXP |
indole-3-carbinol results in decreased activity of CYP2E1 protein indole-3-carbinol inhibits the reaction [Thioacetamide results in increased activity of CYP2E1 protein] |
CTD |
PMID:17582584 PMID:37150287 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2j10 |
cytochrome P450, family 2, subfamily j, polypeptide 10 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CYP2J10 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:110,960,319...110,995,220
Ensembl chr 5:110,960,317...110,995,115
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions increases expression |
EXP |
[indole-3-carbinol co-treated with Phenobarbital] results in increased expression of CYP3A23-3A1 mRNA indole-3-carbinol results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:24418717 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of CYP3A62 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP3A62 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr12:16,397,998...16,433,833
Ensembl chr12:16,397,998...16,433,833
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CYP3A9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP4A8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of CYP7B1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Dab1 |
DAB adaptor protein 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DAB1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DACT2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dapp1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DAPP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:226,425,890...226,475,445
Ensembl chr 2:226,425,898...226,475,423
|
|
G |
Dbn1 |
drebrin 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DBN1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
|
|
G |
Dcun1d1 |
defective in cullin neddylation 1 domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DCUN1D1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:118,721,275...118,772,606
Ensembl chr 2:118,721,822...118,772,602
|
|
G |
Ddah2 |
DDAH family member 2, ADMA-independent |
affects expression |
EXP |
indole-3-carbinol affects the expression of DDAH2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Ddc |
dopa decarboxylase |
affects expression |
EXP |
indole-3-carbinol affects the expression of DDC mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddhd1 |
DDHD domain containing 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DDHD1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
|
|
G |
Ddx21-ps11 |
DExD-box helicase 21, pseudogene 11 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DDX21-PS11 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:16,170,788...16,192,428
|
|
G |
Ddx21-ps9 |
DExD-box helicase 21, pseudogene 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DDX21-PS9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:15,150,261...15,152,679
|
|
G |
Defb105a |
defensin beta 105A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB12 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr16:70,136,218...70,138,645
Ensembl chr16:70,725,701...70,728,143 Ensembl chr16:70,725,701...70,728,143
|
|
G |
Defb18 |
defensin beta 18 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB18 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:20,852,230...20,853,247
Ensembl chr 9:20,852,300...20,853,211
|
|
G |
Defb49 |
defensin beta 49 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DEFB49 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DEFB49 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DEFB49 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 9:20,832,686...20,837,352
Ensembl chr 9:20,832,686...20,837,352
|
|
G |
Degs1l2 |
delta(4)-desaturase, sphingolipid 1 like 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DEGS1L2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:92,831,549...92,839,257
Ensembl chr13:92,831,537...92,839,246
|
|
G |
Derl3 |
derlin 3 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of DERL3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DERL3 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027
|
|
G |
Dhh |
desert hedgehog signaling molecule |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DHH mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DHRS7 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dhrsx |
dehydrogenase/reductase X-linked |
affects expression |
EXP |
indole-3-carbinol affects the expression of DHRSX mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:16,299,768...16,304,553
Ensembl chr12:16,299,808...16,304,552
|
|
G |
Dhx9 |
DExH-box helicase 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DHX9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of DIABLO mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Diaph3 |
diaphanous-related formin 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DIAPH3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
|
|
G |
Dimt1 |
DIM1 rRNA methyltransferase and ribosome maturation factor |
affects expression |
EXP |
indole-3-carbinol affects the expression of DIMT1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:38,343,086...38,368,242
Ensembl chr 2:38,354,854...38,368,227
|
|
G |
Dlg5l17 |
discs large MAGUK scaffold protein 5 like 17 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DLG5L17 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:38,165,288...38,171,353
Ensembl chr 8:38,167,231...38,192,620
|
|
G |
Dmac2l |
distal membrane arm assembly component 2 like |
affects expression |
EXP |
indole-3-carbinol affects the expression of DMAC2L mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933
|
|
G |
Dmbt1 |
deleted in malignant brain tumors 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DMBT1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
|
|
G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DMRT1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
|
|
G |
Dmxl2 |
Dmx-like 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DMXL2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:54,741,164...54,884,948
Ensembl chr 8:54,741,160...54,885,161
|
|
G |
Dnaaf2 |
dynein, axonemal, assembly factor 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DNAAF2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:87,661,101...87,670,267
Ensembl chr 6:87,660,821...87,670,199
|
|
G |
Dnah3 |
dynein, axonemal, heavy chain 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:174,305,929...174,479,490
Ensembl chr 1:174,306,644...174,479,474
|
|
G |
Dnai1 |
dynein, axonemal, intermediate chain 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of DNAI1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925
|
|
G |
Dnajc18 |
DnaJ heat shock protein family (Hsp40) member C18 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DNAJC18 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:27,269,350...27,303,453
Ensembl chr18:27,269,355...27,298,344
|
|
G |
Dnlz |
DNL-type zinc finger |
affects expression |
EXP |
indole-3-carbinol affects the expression of DNLZ mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:9,169,948...9,171,727
Ensembl chr 3:9,169,793...9,180,551
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
affects expression |
EXP |
indole-3-carbinol affects the expression of DNMT3B mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dock3 |
dedicator of cyto-kinesis 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DOCK3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
|
|
G |
Dpep1 |
dipeptidase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DPEP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
|
|
G |
Dppa3-ps1 |
developmental pluripotency-associated 3, pseudogene 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DPPA3-PS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:106,480,217...106,482,060
|
|
G |
Dppa3l4 |
developmental pluripotency associated 3 like 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DPPA3L4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:90,402,832...90,404,317
|
|
G |
Dqx1 |
DEAQ box RNA-dependent ATPase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DQX1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:115,563,497...115,572,598
Ensembl chr 4:115,563,752...115,572,590
|
|
G |
Drg1 |
developmentally regulated GTP binding protein 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DRG1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:78,103,876...78,119,976
Ensembl chr14:78,103,876...78,119,953
|
|
G |
Dtx3 |
deltex E3 ubiquitin ligase 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DTX3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:63,013,769...63,018,431
Ensembl chr 7:63,013,371...63,018,522
|
|
G |
Dusp13b |
dual specificity phosphatase 13B |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of DUSP13B mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DUSP13B mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr15:2,567,432...2,575,105
Ensembl chr15:2,533,547...2,575,539
|
|
G |
Dusp19 |
dual specificity phosphatase 19 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DUSP19 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:65,538,424...65,554,465
Ensembl chr 3:65,538,420...65,553,534
|
|
G |
Dusp4 |
dual specificity phosphatase 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DUSP4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DUSP8 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Dut |
deoxyuridine triphosphatase |
affects expression |
EXP |
indole-3-carbinol affects the expression of DUT mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dync2i1 |
dynein 2 intermediate chain 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DYNC2I1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:137,133,418...137,189,937
Ensembl chr 6:137,133,418...137,188,719
|
|
G |
Dync2li1 |
dynein cytoplasmic 2 light intermediate chain 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of DYNC2LI1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:9,992,537...10,025,355
Ensembl chr 6:9,992,541...10,025,336
|
|
G |
Eef1akmt2 |
EEF1A lysine methyltransferase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EEF1AKMT2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:187,616,156...187,640,934
Ensembl chr 1:187,500,744...187,640,937
|
|
G |
Eeig2 |
EEIG family member 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EEIG2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371
|
|
G |
Efcab3 |
EF-hand calcium binding domain 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFCAB3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:89,583,526...90,077,260
Ensembl chr10:89,644,522...90,077,259
|
|
G |
Efna1 |
ephrin A1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EFNA1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Efna5 |
ephrin A5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EFNA5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:102,316,753...102,595,480
Ensembl chr 9:102,320,295...102,597,413
|
|
G |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EGFLAM mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:56,301,945...56,476,665
Ensembl chr 2:56,302,566...56,476,298
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
indole-3-carbinol results in decreased expression of EGFR protein |
CTD |
PMID:18025290 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EGLN3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EGR1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif2b2 |
eukaryotic translation initiation factor 2B subunit beta |
affects expression |
EXP |
indole-3-carbinol affects the expression of EIF2B2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
|
|
G |
Eif5a2 |
eukaryotic translation initiation factor 5A2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EIF5A2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:111,728,587...111,746,087
Ensembl chr 2:111,729,323...111,746,087
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ELAPOR1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
|
|
G |
Elavl4 |
ELAV like RNA binding protein 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ELAVL4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:125,056,848...125,200,543
Ensembl chr 5:125,056,848...125,200,446
|
|
G |
Elovl1 |
ELOVL fatty acid elongase 1 |
multiple interactions |
EXP |
indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of ELOVL1 mRNA] |
CTD |
PMID:27178563 |
|
NCBI chr 5:131,961,478...131,965,961
Ensembl chr 5:131,961,322...131,965,958
|
|
G |
Elp6 |
elongator acetyltransferase complex subunit 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ELP6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:110,280,059...110,295,070
Ensembl chr 8:110,279,979...110,295,067
|
|
G |
Emb |
embigin |
affects expression |
EXP |
indole-3-carbinol affects the expression of EMB mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
|
|
G |
Emilin2 |
elastin microfibril interfacer 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:111,160,708...111,220,463
Ensembl chr 9:111,160,712...111,220,352
|
|
G |
Eml5 |
EMAP like 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EML5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:118,046,655...118,175,831
Ensembl chr 6:118,046,655...118,175,831
|
|
G |
Emp3 |
epithelial membrane protein 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EMP3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ENC1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ENC1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Eno3 |
enolase 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ENO3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
|
|
G |
Enpep |
glutamyl aminopeptidase |
affects expression |
EXP |
indole-3-carbinol affects the expression of ENPEP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase family member 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ENPP5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:16,910,187...16,917,633
Ensembl chr 9:16,910,831...16,917,480
|
|
G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENPP7 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:104,242,169...104,247,185
Ensembl chr10:104,242,223...104,246,589
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ENTPD5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
|
|
G |
Entrep1 |
endosomal transmembrane epsin interactor 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ENTREP1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
|
|
G |
Entrep3 |
endosomal transmembrane epsin interactor 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ENTREP3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:174,588,984...174,595,281
Ensembl chr 2:174,589,337...174,595,281
|
|
G |
Epcam |
epithelial cell adhesion molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of EPCAM mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Epha1 |
Eph receptor A1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EPHA1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:71,246,409...71,260,846
|
|
G |
Epha2 |
Eph receptor A2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EPHA2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
|
|
G |
Ephb1 |
Eph receptor B1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPHB1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
|
|
G |
Ephb6 |
Eph receptor B6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EPHB6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EPHX1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Eps8 |
EGFR pathway substrate 8, signaling adaptor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EPS8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Eral1 |
Era-like 12S mitochondrial rRNA chaperone 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ERAL1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:62,961,725...62,968,747
Ensembl chr10:62,961,730...62,968,994
|
|
G |
Ercc4l1 |
excision repair cross-complementing rodent repair deficiency, complementation group 4-like 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ERCC4L1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:954,927...983,651
Ensembl chr10:954,977...983,174
|
|
G |
Ermard |
ER membrane-associated RNA degradation |
affects expression |
EXP |
indole-3-carbinol affects the expression of ERMARD mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:55,983,312...56,004,569
Ensembl chr 1:55,983,403...56,002,687
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression multiple interactions |
ISO EXP |
indole-3-carbinol analog results in decreased expression of ESR1 protein BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]]; indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein] indole-3-carbinol inhibits the reaction [bisphenol A results in increased expression of ESR1 protein] |
CTD |
PMID:11110848 PMID:16434996 PMID:20570586 PMID:24257414 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esrra |
estrogen related receptor, alpha |
affects expression |
EXP |
indole-3-carbinol affects the expression of ESRRA mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268
|
|
G |
Exog |
exo/endonuclease G |
affects expression |
EXP |
indole-3-carbinol affects the expression of EXOG mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:119,184,974...119,204,819
Ensembl chr 8:119,185,136...119,204,672
|
|
G |
Exosc2 |
exosome component 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of EXOSC2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:14,962,930...14,973,645
Ensembl chr 3:14,962,917...14,973,575
|
|
G |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of EYA1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:4,863,501...5,101,483
Ensembl chr 5:4,955,543...5,101,483
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of F13A1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
|
|
G |
F13b |
coagulation factor XIII B chain |
affects expression |
EXP |
indole-3-carbinol affects the expression of F13B mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:51,130,908...51,156,383
Ensembl chr13:51,130,920...51,156,381
|
|
G |
Faap24 |
FA core complex associated protein 24 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FAAP24 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:88,051,523...88,057,997
Ensembl chr 1:88,051,911...88,057,989
|
|
G |
Fabp12 |
fatty acid binding protein 12 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FABP12 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:91,539,568...91,554,999
Ensembl chr 2:91,500,539...91,554,996
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FABP4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fads2 |
fatty acid desaturase 2 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of FADS2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FADS2 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fam114a2 |
family with sequence similarity 114, member A2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:41,661,787...41,696,790
Ensembl chr10:41,661,787...41,696,741
|
|
G |
Fam13a |
family with sequence similarity 13, member A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM13A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
|
|
G |
Fam186a |
family with sequence similarity 186 member A |
multiple interactions affects expression |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM186A mRNA indole-3-carbinol affects the expression of FAM186A mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 7:131,043,586...131,102,312
|
|
G |
Fam3d |
FAM3 metabolism regulating signaling molecule D |
affects expression |
EXP |
indole-3-carbinol affects the expression of FAM3D mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:16,538,881...16,574,468
Ensembl chr15:16,539,489...16,573,034
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
affects expression |
EXP |
indole-3-carbinol affects the expression of FAM89A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:52,710,002...52,722,630
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Far1 |
fatty acyl CoA reductase 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAR1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730
|
|
G |
Far2 |
fatty acyl CoA reductase 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FAR2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:180,973,968...181,087,862
Ensembl chr 4:181,007,622...181,087,255
|
|
G |
Fbxo27 |
F-box protein 27 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FBXO27 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:83,965,426...83,987,781
Ensembl chr 1:83,965,986...83,987,778
|
|
G |
Fbxo30 |
F-box protein 30 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FBXO30 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
|
|
G |
Fbxo44 |
F-box protein 44 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FBXO44 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:158,583,363...158,592,510
Ensembl chr 5:158,583,366...158,592,363
|
|
G |
Fcnb |
ficolin B |
affects expression |
EXP |
indole-3-carbinol affects the expression of FCNB mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151
|
|
G |
Fdps-ps4 |
farnesyl diphosphate synthase, pseudogene 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FDPS-PS4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:18,816,786...18,818,020
|
|
G |
Fdxacb1 |
ferredoxin-fold anticodon binding domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FDXACB1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:51,111,831...51,118,253
Ensembl chr 8:51,113,397...51,118,308
|
|
G |
Fer1l5 |
fer-1-like family member 5 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of FER1L5 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FER1L5 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425
|
|
G |
Fgd1 |
FYVE, RhoGEF and PH domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FGD1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:20,023,746...20,066,734
Ensembl chr X:20,023,746...20,066,566
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of FGF1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF12 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FGF2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FGF21 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF21 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FGF21 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FGFR2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
affects expression |
EXP |
indole-3-carbinol affects the expression of FHIT mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FKBP11 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Fkbp3 |
FKBP prolyl isomerase 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FKBP3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:83,113,885...83,125,500
Ensembl chr 6:83,113,786...83,127,011
|
|
G |
Flg |
filaggrin |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FLG mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:178,884,793...178,912,986
|
|
G |
Fmn1 |
formin 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FMN1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
|
|
G |
Fn3k |
fructosamine 3 kinase |
affects expression |
EXP |
indole-3-carbinol affects the expression of FN3K mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:106,700,670...106,715,903
Ensembl chr10:106,700,670...106,715,895
|
|
G |
Fndc5 |
fibronectin type III domain containing 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of FNDC5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:141,481,593...141,491,257
Ensembl chr 5:141,481,590...141,490,731
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in decreased expression of FOS mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in decreased expression of FOS mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxd2 |
forkhead box D2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:128,427,986...128,430,709
Ensembl chr 5:128,429,020...128,430,504
|
|
G |
Foxd4 |
forkhead box D4 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of FOXD4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD4 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:222,557,494...222,559,189
Ensembl chr 1:222,557,360...222,559,159
|
|
G |
Foxo3 |
forkhead box O3 |
increases expression |
ISO |
indole-3-carbinol results in increased expression of FOXO3 protein |
CTD |
PMID:33118390 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Fxc1-ps1 |
fractured callus expressed transcript 1, pseudogene 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FXC1-PS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr20:47,048,327...47,049,191
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FXYD2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
|
|
G |
Fxyd3 |
FXYD domain-containing ion transport regulator 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FXYD3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:86,305,531...86,312,455
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of FXYD6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of G6PC1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45A mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GADD45A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of GADD45B mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GADD45B mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GADD45G mRNA |
CTD |
PMID:22129741 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GALNT16 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Galntl5 |
polypeptide N-acetylgalactosaminyltransferase-like 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GALNTL5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:9,873,426...9,923,297
Ensembl chr 4:9,873,428...9,923,136
|
|
G |
Gapdhl10 |
glyceraldehyde-3-phosphate dehydrogenase like 10 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GAPDHL10 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:15,370,290...15,371,300
Ensembl chr16:15,370,293...15,371,300
|
|
G |
Gapdhl9 |
glyceraldehyde-3-phosphate dehydrogenase like 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GAPDHL9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:210,784,633...210,785,652
|
|
G |
Gar1 |
GAR1 ribonucleoprotein |
affects expression |
EXP |
indole-3-carbinol affects the expression of GAR1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
|
|
G |
Garin3 |
golgi associated RAB2 interactor family member 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GARIN3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:30,829,877...30,833,115
Ensembl chr10:30,829,877...30,833,111
|
|
G |
Gcat |
glycine C-acetyltransferase |
affects expression |
EXP |
indole-3-carbinol affects the expression of GCAT mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
|
|
G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
affects expression |
EXP |
indole-3-carbinol affects the expression of GCNT3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression multiple interactions |
ISO |
indole-3-carbinol results in increased expression of GDF15 [indole-3-carbinol co-treated with resveratrol] results in increased expression of GDF15 |
CTD |
PMID:15670751 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GDNF mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfra3 |
GDNF family receptor alpha 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GFRA3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of GGT1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GGT1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GGT1 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gimd1 |
GIMAP family P-loop NTPase domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GIMD1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:221,103,878...221,138,559
Ensembl chr 2:221,103,878...221,138,553
|
|
G |
Gins4 |
GINS complex subunit 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GINS4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:68,787,572...68,799,938
Ensembl chr16:68,767,339...68,802,273
|
|
G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GIPC2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
|
|
G |
Gkn2 |
gastrokine 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GKN2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:119,778,326...119,824,366
Ensembl chr 4:119,818,280...119,824,363
|
|
G |
Glcci1 |
glucocorticoid induced 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GLCCI1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
|
|
G |
Gldc |
glycine decarboxylase |
affects expression |
EXP |
indole-3-carbinol affects the expression of GLDC mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glmn |
glomulin, FKBP associated protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of GLMN mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:2,187,144...2,231,295
Ensembl chr14:2,187,642...2,230,420
|
|
G |
Glrx |
glutaredoxin |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of GLRX mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLRX mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glt1d1 |
glycosyltransferase 1 domain containing 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GLT1D1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:28,975,984...29,049,707
Ensembl chr12:28,975,988...29,049,695
|
|
G |
Gltp |
glycolipid transfer protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GLTP mRNA |
CTD |
PMID:22129741 |
|
NCBI chr12:41,907,168...41,927,321
Ensembl chr12:41,907,144...41,927,319
|
|
G |
Gnai1 |
G protein subunit alpha i1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GNAI1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
|
|
G |
Gnptab |
N-acetylglucosamine-1-phosphate transferase subunits alpha and beta |
affects expression |
EXP |
indole-3-carbinol affects the expression of GNPTAB mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:22,800,502...22,866,336
Ensembl chr 7:22,800,485...22,866,933
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GNRH1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
EXP |
indole-3-carbinol affects the reaction [Thioacetamide results in increased expression of GOT1 protein] |
CTD |
PMID:37150287 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gp2 |
glycoprotein 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GP2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 1:173,797,057...173,812,619
Ensembl chr 1:173,797,057...173,812,619
|
|
G |
Gp5 |
glycoprotein V (platelet) |
affects expression |
EXP |
indole-3-carbinol affects the expression of GP5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:70,443,613...70,446,705
Ensembl chr11:70,443,613...70,446,705
|
|
G |
Gpa33 |
glycoprotein A33 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GPA33 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:78,381,141...78,414,765
Ensembl chr13:78,381,141...78,414,765
|
|
G |
Gpatch4 |
G patch domain containing 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GPATCH4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:173,499,700...173,520,346
Ensembl chr 2:173,509,897...173,518,684
|
|
G |
Gpbar1 |
G protein-coupled bile acid receptor 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPBAR1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:75,860,758...75,863,260
Ensembl chr 9:75,860,677...75,863,168
|
|
G |
Gpc3 |
glypican 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GPC3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
|
|
G |
Gpc5 |
glypican 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPC5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPC5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPC5 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
|
|
G |
Gpr153 |
G protein-coupled receptor 153 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR153 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971
|
|
G |
Gpr20 |
G protein-coupled receptor 20 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR20 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430
|
|
G |
Gpr55 |
G protein-coupled receptor 55 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of GPR55 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPR55 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPR55 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr 9:86,584,906...86,640,601
Ensembl chr 9:86,590,885...86,640,613
|
|
G |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPRIN1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr17:9,863,881...9,876,832
Ensembl chr17:9,863,571...9,876,915
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
indole-3-carbinol affects the reaction [Thioacetamide results in increased expression of GPT protein] |
CTD |
PMID:37150287 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
affects expression multiple interactions increases expression |
EXP |
indole-3-carbinol affects the expression of GPX2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GPX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA] indole-3-carbinol results in increased expression of GPX2 mRNA |
CTD |
PMID:21203749 PMID:21396975 PMID:22129741 PMID:24418717 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Grifin |
galectin-related inter-fiber protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of GRIFIN mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:14,080,170...14,082,892
Ensembl chr12:14,080,910...14,082,877
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
affects expression increases expression |
EXP |
indole-3-carbinol affects the expression of GRIN2C mRNA indole-3-carbinol results in increased expression of GRIN2C mRNA |
CTD |
PMID:21396975 PMID:23824016 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Grk5 |
G protein-coupled receptor kinase 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GRK5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
|
|
G |
Gsn |
gelsolin |
affects expression |
EXP |
indole-3-carbinol affects the expression of GSN mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression multiple interactions |
EXP |
indole-3-carbinol results in increased expression of GSTA2 mRNA [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA2 mRNA |
CTD |
PMID:11446830 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression multiple interactions |
EXP |
indole-3-carbinol results in increased expression of GSTA3 mRNA; indole-3-carbinol results in increased expression of GSTA3 protein [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA3 mRNA; [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA3 protein |
CTD |
PMID:9794803 PMID:11446830 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
affects expression increases expression |
EXP |
indole-3-carbinol affects the expression of GSTA4 mRNA indole-3-carbinol results in increased expression of GSTA4 protein |
CTD |
PMID:9794803 PMID:21396975 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
multiple interactions increases activity increases expression affects expression |
EXP |
[indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 mRNA; [indole-3-carbinol co-treated with 1-cyano-2-hydroxy-3-butene] results in increased expression of GSTA5 protein; [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTA5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTA5 mRNA] indole-3-carbinol results in increased activity of GSTA5 protein indole-3-carbinol results in increased expression of GSTA5; indole-3-carbinol results in increased expression of GSTA5 mRNA; indole-3-carbinol results in increased expression of GSTA5 protein indole-3-carbinol affects the expression of GSTA5 mRNA |
CTD |
PMID:9328168 PMID:9794803 PMID:9806166 PMID:11446830 PMID:21396975 PMID:22129741 More...
|
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression multiple interactions |
ISO EXP |
indole-3-carbinol results in increased expression of GSTM1 protein [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM1 mRNA |
CTD |
PMID:11309284 PMID:22129741 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
affects expression multiple interactions increases expression |
EXP ISO |
indole-3-carbinol affects the expression of GSTM2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM2 mRNA indole-3-carbinol results in increased expression of GSTM5 protein |
CTD |
PMID:11309284 PMID:21396975 PMID:22129741 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of GSTM4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM4 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
affects expression multiple interactions increases expression |
EXP |
indole-3-carbinol affects the expression of GSTM3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM3 mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GSTM3 mRNA indole-3-carbinol results in increased expression of GSTM3 mRNA; indole-3-carbinol results in increased expression of GSTM3 protein |
CTD |
PMID:9794803 PMID:21396975 PMID:22129741 PMID:24418717 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gsto2 |
glutathione S-transferase omega 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GSTO2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:246,731,314...246,757,592
Ensembl chr 1:246,732,089...246,753,866
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
affects expression multiple interactions increases expression |
EXP ISO |
indole-3-carbinol affects the expression of GSTP1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTP1 mRNA] indole-3-carbinol results in increased expression of GSTP1 protein indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased expression of GSTP1 protein] [indole-3-carbinol co-treated with phenethyl isothiocyanate] results in increased expression of GSTP1 mRNA; [indole-3-carbinol co-treated with xanthohumol] results in increased expression of GSTP1 mRNA |
CTD |
PMID:9794803 PMID:21396975 PMID:22129741 PMID:29775573 PMID:32070777 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression affects expression |
EXP |
indole-3-carbinol results in increased expression of GSTT1 mRNA; indole-3-carbinol results in increased expression of GSTT1 protein indole-3-carbinol affects the expression of GSTT1 mRNA |
CTD |
PMID:9794803 PMID:10413528 PMID:21396975 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GTDC1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:28,766,640...29,161,668
Ensembl chr 3:28,766,645...29,162,271
|
|
G |
Gtf2h5 |
general transcription factor IIH subunit 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GTF2H5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:46,656,804...46,663,512
Ensembl chr 1:46,656,859...46,664,939
|
|
G |
Gtpbp10 |
GTP binding protein 10 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GTPBP10 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:28,476,857...28,494,375
Ensembl chr 4:28,476,857...28,494,375
|
|
G |
Gtpbp8 |
GTP binding protein 8 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GTPBP8 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:55,945,778...55,955,743
Ensembl chr11:55,945,795...55,955,635
|
|
G |
Gxylt1 |
glucoside xylosyltransferase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of GXYLT1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699
|
|
G |
H3f3al3 |
H3.3 histone A like 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of H3F3AL3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:42,494,007...42,495,112
Ensembl chr 9:42,494,353...42,494,763
|
|
G |
Hacd1 |
3-hydroxyacyl-CoA dehydratase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HACD1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:77,081,508...77,106,114
Ensembl chr17:77,083,740...77,106,073
|
|
G |
Hal |
histidine ammonia lyase |
affects expression |
EXP |
indole-3-carbinol affects the expression of HAL mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
affects expression |
EXP |
indole-3-carbinol affects the expression of HAMP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HAO2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Haus1 |
HAUS augmin-like complex, subunit 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HAUS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:71,275,417...71,286,626
Ensembl chr18:71,273,537...71,286,660
|
|
G |
Hbb |
hemoglobin subunit beta |
affects expression |
EXP |
indole-3-carbinol affects the expression of HBB mRNA; indole-3-carbinol affects the expression of HBB-B1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC1 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac2 |
histone deacetylase 2 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC2 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hdac4 |
histone deacetylase 4 |
multiple interactions |
ISO |
indole-3-carbinol promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC4 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hdac6 |
histone deacetylase 6 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC6 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
|
|
G |
Hdac8 |
histone deacetylase 8 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC8 mRNA] |
CTD |
PMID:24200994 |
|
NCBI chr X:67,385,288...67,593,014
Ensembl chr X:67,385,289...67,592,923
|
|
G |
Hdc |
histidine decarboxylase |
affects expression |
EXP |
indole-3-carbinol affects the expression of HDC mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
|
|
G |
Hddc2 |
HD domain containing 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HDDC2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:26,294,030...26,313,914
Ensembl chr 1:26,294,030...26,313,935
|
|
G |
Hebp2 |
heme binding protein 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HEBP2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777
|
|
G |
Hells |
helicase, lymphoid specific |
affects expression |
EXP |
indole-3-carbinol affects the expression of HELLS mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Helz2 |
helicase with zinc finger 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HELZ2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:168,338,813...168,353,219
Ensembl chr 3:168,338,813...168,353,159
|
|
G |
Hhip |
Hedgehog-interacting protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HHIP mRNA |
CTD |
PMID:22129741 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hid1 |
HID1 domain containing |
affects expression |
EXP |
indole-3-carbinol affects the expression of HID1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:100,589,555...100,610,050
Ensembl chr10:100,589,555...100,610,041
|
|
G |
Hira |
histone cell cycle regulator |
affects expression |
EXP |
indole-3-carbinol affects the expression of HIRA mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:82,024,469...82,133,212
Ensembl chr11:82,024,469...82,133,529
|
|
G |
Hist1h2ah |
histone cluster 1 H2A family member H |
affects expression |
EXP |
indole-3-carbinol affects the expression of HIST1H2AH mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:41,384,521...41,385,018
|
|
G |
hist1h2ail2 |
histone cluster 1, H2ai-like2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HIST1H2AIL2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:42,753,160...42,753,620
Ensembl chr17:41,534,691...41,539,869 Ensembl chr17:41,534,691...41,539,869
|
|
G |
Hlcs |
holocarboxylase synthetase |
affects expression |
EXP |
indole-3-carbinol affects the expression of HLCS mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hltf |
helicase-like transcription factor |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HLTF mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:102,549,724...102,609,327
|
|
G |
Hmg20a |
high mobility group 20A |
affects expression |
EXP |
indole-3-carbinol affects the expression of HMG20A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:56,819,673...56,895,658
Ensembl chr 8:56,819,659...56,895,656
|
|
G |
Hmgb1-ps31 |
high-mobility group box 1, pseudogene 31 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HMGB1-PS31 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:37,968,898...37,969,438
|
|
G |
Hmgb2 |
high mobility group box 2 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of HMGB2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HMGB2 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G |
Hmgb4-ps5 |
high-mobility group box 4, pseudogene 5 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HMGB4-PS5 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:126,731,922...126,732,399
Ensembl chr X:136,290,233...136,290,934
|
|
G |
Hmgb4l7 |
high-mobility group box 4 like 7 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HMGB4L7 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:135,622,322...135,623,034
Ensembl chr X:135,622,361...135,623,009 Ensembl chr X:135,622,361...135,623,009
|
|
G |
Hmgb4l8 |
high-mobility group box 4 like 8 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HMGB4L8 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:129,470,473...129,471,169
Ensembl chr X:129,470,475...129,471,174 Ensembl chr X:129,470,475...129,471,174
|
|
G |
Hmgb4l9 |
high-mobility group box 4 like 9 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HMGB4L9 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:134,184,390...134,185,772
Ensembl chr X:134,184,560...134,185,264
|
|
G |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HMGN3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP ISO |
indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of HMOX1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in decreased expression of HMOX1 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in decreased expression of HMOX1 protein]] indole-3-carbinol inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 protein] |
CTD |
PMID:28619389 PMID:29775573 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4g |
hepatocyte nuclear factor 4, gamma |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of HNF4G mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:97,885,773...98,036,650
Ensembl chr 2:97,887,432...98,036,592
|
|
G |
Hoxc13 |
homeobox C13 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HOXC13 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:134,058,640...134,065,479
Ensembl chr 7:134,058,640...134,064,800
|
|
G |
Hpgds |
hematopoietic prostaglandin D synthase |
affects expression |
EXP |
indole-3-carbinol affects the expression of HPGDS mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
|
|
G |
Hps3 |
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of HPS3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:102,484,574...102,527,580
Ensembl chr 2:102,484,574...102,526,047
|
|
G |
Hpse |
heparanase |
affects expression |
EXP |
indole-3-carbinol affects the expression of HPSE mRNA |
CTD |
PMID:21396975 |
|
NCBI chr14:8,896,593...8,937,011
Ensembl chr14:8,896,593...8,937,010
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HSDL2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
indole-3-carbinol results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of HTATIP2 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of HTATIP2 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Ica1 |
islet cell autoantigen 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ICA1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions decreases expression |
ISO |
[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of ICAM1 protein; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] indole-3-carbinol results in decreased expression of ICAM1 protein |
CTD |
PMID:21948866 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
multiple interactions |
EXP |
indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of ID3 mRNA] |
CTD |
PMID:27178563 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Idi2 |
isopentenyl-diphosphate delta isomerase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of IDI2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:61,331,385...61,334,987
Ensembl chr17:61,331,669...61,334,285
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
increases expression multiple interactions |
ISO |
indole-3-carbinol results in increased expression of IDO1 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of IDO1 mRNA] |
CTD |
PMID:21948866 |
|
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ido2 |
indoleamine 2,3-dioxygenase 2 |
increases expression multiple interactions |
ISO |
indole-3-carbinol results in increased expression of IDO2 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in increased expression of IDO2 mRNA] |
CTD |
PMID:21948866 |
|
NCBI chr16:67,459,158...67,498,052
Ensembl chr16:67,459,190...67,496,324
|
|
G |
Ifna12l |
interferon alpha 12 like |
affects expression |
EXP |
indole-3-carbinol affects the expression of IFNA12L mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:103,476,362...103,477,427
Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211
|
|
G |
Ifng |
interferon gamma |
decreases secretion multiple interactions |
ISO |
indole-3-carbinol results in decreased secretion of IFNG protein indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IFNG protein] |
CTD |
PMID:21948866 PMID:24200994 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ift43 |
intraflagellar transport 43 |
affects expression |
EXP |
indole-3-carbinol affects the expression of IFT43 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:105,729,734...105,806,257
Ensembl chr 6:105,729,792...105,806,257
|
|
G |
Ift74 |
intraflagellar transport 74 |
affects expression |
EXP |
indole-3-carbinol affects the expression of IFT74 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:109,474,255...109,563,833
|
|
G |
Iftap |
intraflagellar transport associated protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of IFTAP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
affects expression |
EXP |
indole-3-carbinol affects the expression of IGFALS mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IGFBP1 mRNA] |
CTD |
PMID:22129741 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased activity of IKBKB protein] |
CTD |
PMID:15811958 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Ikbke |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
affects expression |
EXP |
indole-3-carbinol affects the expression of IKBKE mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of IKZF1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases secretion |
ISO EXP |
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of IL10 mRNA; [Lipopolysaccharides co-treated with indole-3-carbinol] results in increased secretion of IL10 protein; AHR protein affects the susceptibility to [[Lipopolysaccharides co-treated with indole-3-carbinol] results in increased secretion of IL10 protein]; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] indole-3-carbinol results in decreased secretion of IL10 protein indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of IL10 protein]; indole-3-carbinol inhibits the reaction [Thioacetamide results in decreased expression of IL10 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of IL10 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of IL10 protein]] |
CTD |
PMID:21948866 PMID:28619389 PMID:37150287 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased expression of IL12A mRNA]; indole-3-carbinol inhibits the reaction [Poly I-C results in increased expression of IL12A mRNA] |
CTD |
PMID:27783115 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12rb1 |
interleukin 12 receptor subunit beta 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of IL12RB1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
|
|
G |
Il17d |
interleukin 17D |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IL17D mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:31,671,337...31,688,833
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]; indole-3-carbinol inhibits the reaction [IL1B protein results in increased activity of RELA protein]; indole-3-carbinol promotes the reaction [CL 075 results in increased expression of IL1B mRNA]; indole-3-carbinol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased secretion of IL1B protein; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] |
CTD |
PMID:15811958 PMID:21948866 PMID:27783115 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL2 protein] |
CTD |
PMID:24200994 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il27 |
interleukin 27 |
decreases expression multiple interactions |
ISO |
indole-3-carbinol results in decreased expression of IL27 mRNA Lipopolysaccharides affects the susceptibility to [indole-3-carbinol results in decreased expression of IL27 mRNA] |
CTD |
PMID:21948866 |
|
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
|
|
G |
Il33 |
interleukin 33 |
affects expression |
EXP |
indole-3-carbinol affects the expression of IL33 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il36b |
interleukin 36, beta |
affects expression |
EXP |
indole-3-carbinol affects the expression of IL36B mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:7,024,881...7,030,388
Ensembl chr 3:7,021,973...7,031,619
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO EXP |
indole-3-carbinol results in increased expression of IL6 mRNA [Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased secretion of IL6 protein; [Lipopolysaccharides co-treated with indole-3-carbinol] results in increased expression of IL6 mRNA; indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IL6 protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] indole-3-carbinol inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] |
CTD |
PMID:18025290 PMID:21948866 PMID:24200994 PMID:29775573 PMID:37150287 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Inhbc |
inhibin subunit beta C |
affects expression |
EXP |
indole-3-carbinol affects the expression of INHBC mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:63,184,141...63,197,630
Ensembl chr 7:63,184,142...63,197,630
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of INS1 protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [Letrozole results in increased expression of INS1 protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [Letrozole results in increased expression of INS1 protein]] |
CTD |
PMID:28619389 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Insig1 |
insulin induced gene 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Insyn1 |
inhibitory synaptic factor 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of INSYN1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:58,904,153...58,914,850
Ensembl chr 8:58,904,153...58,914,843
|
|
G |
Ipo7 |
importin 7 |
affects expression |
EXP |
indole-3-carbinol affects the expression of IPO7 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:164,062,702...164,102,938
Ensembl chr 1:164,062,702...164,102,938
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRF1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irgm |
immunity-related GTPase M |
affects expression |
EXP |
indole-3-carbinol affects the expression of IRGM mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Irs2 |
insulin receptor substrate 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of IRS2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Itgax |
integrin subunit alpha X |
multiple interactions decreases expression |
ISO |
[Lipopolysaccharides co-treated with indole-3-carbinol] results in decreased expression of ITGAX protein; AHR protein affects the susceptibility to [indole-3-carbinol results in decreased expression of ITGAX protein]; indole-3-carbinol inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAX protein] |
CTD |
PMID:21948866 |
|
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
|
|
G |
Itgb1bp2 |
integrin subunit beta 1 binding protein 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ITGB1BP2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:66,572,537...66,577,174
Ensembl chr X:66,572,537...66,577,174
|
|
G |
Itgb3bp |
integrin subunit beta 3 binding protein |
affects expression |
EXP |
indole-3-carbinol affects the expression of ITGB3BP mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
|
|
G |
Itgb6 |
integrin subunit beta 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ITGB6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
EXP ISO |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of JUN mRNA; [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of JUN mRNA indole-3-carbinol results in increased expression of JUN mRNA indole-3-carbinol results in increased expression of JUN protein |
CTD |
PMID:22129741 PMID:24418717 PMID:29992829 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Ka11 |
type I keratin KA11 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of KA11 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KA11 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr10:85,161,424...85,164,737
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Katnal2 |
katanin catalytic subunit A1 like 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KATNAL2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:70,531,759...70,607,886
Ensembl chr18:70,531,754...70,608,082
|
|
G |
Kcnh5 |
potassium voltage-gated channel subfamily H member 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNH5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107
|
|
G |
Kcnn2 |
potassium calcium-activated channel subfamily N member 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KCNN2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
|
|
G |
Kcnq2 |
potassium voltage-gated channel subfamily Q member 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KCNQ2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:168,194,776...168,253,831
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Kcnq5 |
potassium voltage-gated channel subfamily Q member 5 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCNQ5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 9:23,830,185...24,395,984
Ensembl chr 9:23,833,087...24,394,704
|
|
G |
Kctd12 |
potassium channel tetramerization domain containing 12 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KCTD12 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:79,800,078...79,806,017
Ensembl chr15:79,801,191...79,806,282
|
|
G |
Kctd4 |
potassium channel tetramerization domain containing 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KCTD4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KCTD4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr15:51,263,664...51,278,030
Ensembl chr15:51,274,295...51,277,499
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
ISO |
indole-3-carbinol inhibits the reaction [Doxorubicin results in increased expression of KEAP1 protein] |
CTD |
PMID:29775573 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Kiaa1671 |
KIAA1671 homolog |
affects expression |
EXP |
indole-3-carbinol affects the expression of KIAA1671 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:43,409,479...43,552,152
Ensembl chr12:43,411,069...43,552,157
|
|
G |
Kif14 |
kinesin family member 14 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KIF14 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
|
|
G |
Kif1c |
kinesin family member 1C |
affects expression |
EXP |
indole-3-carbinol affects the expression of KIF1C mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:55,414,412...55,444,587
Ensembl chr10:55,415,900...55,443,545
|
|
G |
Kif20a |
kinesin family member 20A |
affects expression |
EXP |
indole-3-carbinol affects the expression of KIF20A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
|
|
G |
Kif26b |
kinesin family member 26B |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIF26B mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:90,282,821...90,689,058
Ensembl chr13:90,283,404...90,682,811
|
|
G |
Kif2a |
kinesin family member 2A |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIF2A mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:38,367,998...38,431,237
Ensembl chr 2:38,367,998...38,431,508
|
|
G |
Kif3a |
kinesin family member 3a |
affects expression |
EXP |
indole-3-carbinol affects the expression of KIF3A mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:37,725,930...37,761,183
Ensembl chr10:37,725,970...37,759,191
|
|
G |
Kifc3 |
kinesin family member C3 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of KIFC3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIFC3 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr19:9,825,114...9,920,371
Ensembl chr19:9,886,693...9,920,451
|
|
G |
Kirrel1 |
kirre like nephrin family adhesion molecule 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KIRREL1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:172,521,644...172,615,057
Ensembl chr 2:172,525,245...172,615,299
|
|
G |
Klf6 |
KLF transcription factor 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KLF6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Klhl23 |
kelch-like family member 23 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KLHL23 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:54,580,788...54,594,530
Ensembl chr 3:54,580,961...54,594,530
|
|
G |
Klhl4 |
kelch-like family member 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KLHL4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr X:79,429,193...79,719,482
Ensembl chr X:79,622,113...79,719,480
|
|
G |
Klk7 |
kallikrein-related peptidase 7 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KLK7 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:94,267,170...94,271,361
Ensembl chr 1:94,266,605...94,271,332
|
|
G |
Knop1 |
lysine-rich nucleolar protein 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KNOP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:173,180,400...173,199,253
Ensembl chr 1:173,180,405...173,202,245
|
|
G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KNSTRN mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
|
|
G |
Kpna6 |
karyopherin subunit alpha 6 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KPNA6 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:141,988,111...142,021,483
Ensembl chr 5:141,991,568...142,021,120
|
|
G |
Kremen2 |
kringle containing transmembrane protein 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of KREMEN2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:12,763,345...12,767,622
Ensembl chr10:12,763,397...12,767,854
|
|
G |
Krt14 |
keratin 14 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRT14 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt19 |
keratin 19 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRT19 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt20 |
keratin 20 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRT20 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
|
|
G |
Krt35 |
keratin 35 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KRT35 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:85,026,171...85,029,568
Ensembl chr10:85,026,171...85,029,568
|
|
G |
Krt4 |
keratin 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of KRT4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:133,046,067...133,052,027
Ensembl chr 7:133,046,515...133,052,019
|
|
G |
Krt78 |
keratin 78 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRT78 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:133,074,193...133,081,536
Ensembl chr 7:133,074,215...133,082,021
|
|
G |
Krtap10-10l1 |
keratin associated protein 10-10 like 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRTAP10-10L1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr20:10,824,177...10,825,590
|
|
G |
Krtap14 |
keratin associated protein 14 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRTAP14 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:28,126,660...28,127,502
Ensembl chr11:28,126,660...28,127,502
|
|
G |
Krtap2-4l2 |
keratin associated protein 2-4 like 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRTAP2-4 mRNA; indole-3-carbinol affects the expression of KRTAP2-4L2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:84,584,364...84,585,548
Ensembl chr10:84,584,363...84,584,808
|
|
G |
Krtap3-2 |
keratin associated protein 3-2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of KRTAP3-2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:84,518,634...84,518,964
Ensembl chr10:84,517,977...84,518,988 Ensembl chr10:84,517,977...84,518,988
|
|
G |
Lama3 |
laminin subunit alpha 3 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAMA3 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Lamc2 |
laminin subunit gamma 2 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAMC2 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
|
|
G |
Las1l |
LAS1-like, ribosome biogenesis factor |
affects expression |
EXP |
indole-3-carbinol affects the expression of LAS1L mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:60,851,969...60,873,717
Ensembl chr X:60,851,962...60,873,687
|
|
G |
Layn |
layilin |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAYN mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:51,363,928...51,384,748
Ensembl chr 8:51,367,091...51,384,330
|
|
G |
Lce1f |
late cornified envelope 1F |
affects expression |
EXP |
indole-3-carbinol affects the expression of LCE1F mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:178,305,786...178,307,372
Ensembl chr 2:178,305,786...178,307,372
|
|
G |
Leap2 |
liver enriched antimicrobial peptide 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LEAP2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:37,580,172...37,581,244
Ensembl chr10:37,577,855...37,581,244
|
|
G |
Lgals1 |
galectin 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LGALS1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Lgals2 |
galectin 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LGALS2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802
|
|
G |
Lgalsl |
galectin-like |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LGALSL mRNA |
CTD |
PMID:22129741 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
indole-3-carbinol inhibits the reaction [letrozole results in increased expression of LHB protein]; indole-3-carbinol promotes the reaction [Linagliptin inhibits the reaction [letrozole results in increased expression of LHB protein]]; Linagliptin promotes the reaction [indole-3-carbinol inhibits the reaction [letrozole results in increased expression of LHB protein]] |
CTD |
PMID:28619389 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhx8 |
LIM homeobox 8 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LHX8 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:243,244,958...243,269,624
Ensembl chr 2:243,244,961...243,269,416
|
|
G |
Liph |
lipase H |
affects expression |
EXP |
indole-3-carbinol affects the expression of LIPH mRNA |
CTD |
PMID:21396975 |
|
NCBI chr11:79,032,229...79,081,625
Ensembl chr11:79,033,312...79,081,625
|
|
G |
Lipi |
lipase I |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LIPI mRNA |
CTD |
PMID:22129741 |
|
NCBI chr11:14,189,323...14,228,992
Ensembl chr11:14,189,323...14,228,985
|
|
G |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LONRF1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:55,984,572...56,015,156
Ensembl chr16:55,984,463...56,015,156
|
|
G |
Loxl1 |
lysyl oxidase-like 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LOXL1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
|
|
G |
Lpin1 |
lipin 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LPIN1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lpin2 |
lipin 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LPIN2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
|
|
G |
Lpl |
lipoprotein lipase |
affects expression |
EXP |
indole-3-carbinol affects the expression of LPL mRNA |
CTD |
PMID:21396975 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lpo |
lactoperoxidase |
affects expression |
EXP |
indole-3-carbinol affects the expression of LPO mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
|
|
G |
Lrrc51 |
leucine rich repeat containing 51 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LRRC51 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 1:156,278,617...156,297,838
Ensembl chr 1:156,278,618...156,297,773
|
|
G |
Lrrcc1 |
leucine rich repeat and coiled-coil centrosomal protein 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRCC1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 2:87,025,671...87,060,313
Ensembl chr 2:87,025,598...87,060,294
|
|
G |
Lrrn4 |
leucine rich repeat neuronal 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRN4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 3:120,138,093...120,150,877
Ensembl chr 3:120,139,410...120,150,831
|
|
G |
Lsm3 |
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated |
affects expression |
EXP |
indole-3-carbinol affects the expression of LSM3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:124,021,023...124,027,269
Ensembl chr 4:124,021,023...124,027,269
|
|
G |
Lsm5 |
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LSM5 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 4:85,951,073...85,954,289
Ensembl chr 6:104,652,477...104,654,165 Ensembl chr 4:104,652,477...104,654,165
|
|
G |
Lxn |
latexin |
affects expression |
EXP |
indole-3-carbinol affects the expression of LXN mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:151,727,556...151,733,426
Ensembl chr 2:151,727,102...151,733,460
|
|
G |
Ly49si1 |
immunoreceptor Ly49si1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LY49SI1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:163,586,930...163,600,528
Ensembl chr 4:163,514,541...163,751,214 Ensembl chr 4:163,514,541...163,751,214
|
|
G |
Ly9 |
lymphocyte antigen 9 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of LY9 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LY9 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr13:84,079,345...84,100,783
Ensembl chr13:84,079,458...84,100,823
|
|
G |
Ly96 |
lymphocyte antigen 96 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LY96 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
|
|
G |
Lyg2 |
lysozyme G2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LYG2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:40,141,144...40,150,821
Ensembl chr 9:40,141,381...40,150,821
|
|
G |
Lynx1 |
Ly6/neurotoxin 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of LYNX1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 7:106,632,800...106,638,003
Ensembl chr 7:106,632,797...106,638,023
|
|
G |
Lypd1 |
Ly6/Plaur domain containing 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LYPD1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
|
|
G |
Lyplal1 |
lysophospholipase-like 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYPLAL1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr13:97,626,568...97,657,901
Ensembl chr13:97,626,451...97,657,867
|
|
G |
Lyset |
lysosomal enzyme trafficking factor |
affects expression |
EXP |
indole-3-carbinol affects the expression of LYSET mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:121,884,577...121,886,319
Ensembl chr 6:121,884,643...121,886,275
|
|
G |
Lyzl4 |
lysozyme-like 4 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of LYZL4 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 8:121,248,129...121,255,366
Ensembl chr 8:121,248,168...121,255,353
|
|
G |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MACROD2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
|
|
G |
Maged2 |
MAGE family member D2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MAGED2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:19,733,593...19,741,769
Ensembl chr X:19,733,597...19,740,477
|
|
G |
Magee1 |
MAGE family member E1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MAGEE1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr X:70,189,242...70,192,789
Ensembl chr X:70,189,187...70,192,810
|
|
G |
Magoh |
mago homolog, exon junction complex subunit |
affects expression |
EXP |
indole-3-carbinol affects the expression of MAGOH mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:122,639,268...122,646,650
Ensembl chr 5:122,639,308...122,646,617
|
|
G |
Mall |
mal, T-cell differentiation protein-like |
affects expression |
EXP |
indole-3-carbinol affects the expression of MALL mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
affects expression multiple interactions |
EXP ISO |
indole-3-carbinol affects the expression of MAP3K5 mRNA Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein]; indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein |
CTD |
PMID:21396975 PMID:33118390 |
|
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MAP4K4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
indole-3-carbinol results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:33118390 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
indole-3-carbinol results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:33118390 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of MAPKAPK3 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA] |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mapt |
microtubule-associated protein tau |
affects expression |
EXP |
indole-3-carbinol affects the expression of MAPT mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Marchf3 |
membrane associated ring-CH-type finger 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MARCHF3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:50,237,218...50,389,343
Ensembl chr18:50,237,230...50,389,150
|
|
G |
Max |
MYC associated factor X |
affects expression |
EXP |
indole-3-carbinol affects the expression of MAX mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 6:95,636,859...95,662,204
Ensembl chr 6:95,636,858...95,662,137
|
|
G |
Mcam |
melanoma cell adhesion molecule |
affects expression |
EXP |
indole-3-carbinol affects the expression of MCAM mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
|
|
G |
Mcpt1l3 |
mast cell protease 1-like 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MCPT1L3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:29,836,398...29,841,731
Ensembl chr15:29,532,079...29,873,922
|
|
G |
Mcpt8l2 |
mast cell protease 8-like 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MCPT1L2 mRNA |
CTD |
PMID:21396975 |
|
|
|
G |
Mdp1 |
magnesium-dependent phosphatase 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MDP1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:29,148,994...29,151,868
Ensembl chr15:29,148,994...29,151,905
|
|
G |
Me1 |
malic enzyme 1 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of ME1 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ME1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ME1 mRNA] |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Me2 |
malic enzyme 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of ME2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr18:67,350,833...67,400,987
Ensembl chr18:67,355,795...67,400,987
|
|
G |
Med19 |
mediator complex subunit 19 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MED19 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:69,762,138...69,772,661
Ensembl chr 3:69,762,166...69,772,036
|
|
G |
Med21 |
mediator complex subunit 21 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MED21 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
|
|
G |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
affects expression |
EXP |
indole-3-carbinol affects the expression of METAP1D mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:56,279,471...56,354,518
Ensembl chr 3:56,279,493...56,351,981
|
|
G |
Metrnl |
meteorin-like, glial cell differentiation regulator |
affects expression |
EXP |
indole-3-carbinol affects the expression of METRNL mRNA |
CTD |
PMID:21396975 |
|
NCBI chr10:106,963,880...106,977,875
Ensembl chr10:106,963,880...106,977,869
|
|
G |
Mfap4 |
microfibril associated protein 4 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of MFAP4 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MFAP4 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
|
|
G |
Mgme1 |
mitochondrial genome maintenance exonuclease 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MGME1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 3:131,640,770...131,649,933
Ensembl chr 3:131,640,944...131,649,932
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MGST2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mier1 |
MIER1 transcriptional regulator |
affects expression |
EXP |
indole-3-carbinol affects the expression of MIER1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 5:117,876,012...117,927,592
Ensembl chr 5:117,870,382...117,927,589
|
|
G |
Mindy2 |
MINDY lysine 48 deubiquitinase 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MINDY2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453
|
|
G |
Mindy4 |
MINDY lysine 48 deubiquitinase 4 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MINDY4 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 4:84,358,660...84,469,189
Ensembl chr 4:84,358,902...84,463,395
|
|
G |
Misp3 |
MISP family member 3 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MISP3 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr19:24,139,998...24,142,006
Ensembl chr19:24,140,033...24,142,631
|
|
G |
Mlc1 |
modulator of VRAC current 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of MLC1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr 7:120,046,705...120,067,049
Ensembl chr 7:120,046,705...120,067,049
|
|
G |
Mllt6 |
MLLT6, PHD finger containing |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MLLT6 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr10:82,657,258...82,678,899
Ensembl chr10:82,656,872...82,676,073
|
|
G |
Mmd2 |
monocyte to macrophage differentiation-associated 2 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MMD2 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr12:11,962,733...12,009,776
Ensembl chr12:11,962,757...12,009,773
|
|
G |
Mmgt1 |
membrane magnesium transporter 1 |
multiple interactions |
EXP |
[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MMGT1 mRNA |
CTD |
PMID:22129741 |
|
NCBI chr X:134,408,463...134,420,798
Ensembl chr X:134,408,466...134,420,729
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MMP12 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MMP14 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp27 |
matrix metallopeptidase 27 |
affects expression multiple interactions |
EXP |
indole-3-carbinol affects the expression of MMP27 mRNA [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MMP27 mRNA |
CTD |
PMID:21396975 PMID:22129741 |
|
NCBI chr 8:4,745,887...4,755,806
Ensembl chr 8:4,745,883...4,755,806
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of MMP9 protein] indole-3-carbinol results in decreased expression of MMP9 protein |
CTD |
PMID:15811958 PMID:29775573 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mnd1 |
meiotic nuclear divisions 1 |
affects expression |
EXP |
indole-3-carbinol affects the expression of MND1 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096
|
|
G |
Mnda |
myeloid cell nuclear differentiation antigen |
affects expression |
EXP |
indole-3-carbinol affects the expression of IFI204 mRNA |
CTD |
PMID:21396975 |
|
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
|
| |